$34.97
0.792.31%
Last update: Nov 11, 4:00 PM
SpyGlass Pharma Inc
SGPNASDAQ
SpyGlass Pharma rose 29.5% from $26.40 to $34.18, ahead of the S&P 500's +8.6%. Its worst day was Jul 1 (−12.5%), and its low came Jun 16 at $17.56.
Feb 6, 2026 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-5.72 was reported on $0.00 revenue.
−10.3% · S&P 500 −1.7%
SpyGlass Pharma shares rose 15.0%, while the S&P 500 rose 1.0%.
Story events cover the past 12 months · Times ET
+15.0%, the year's best day · S&P 500 +1.0%
EPS of $-0.69 missed the $-0.42 estimate on $0.00 revenue.
−4.4% · S&P 500 −1.2%
SpyGlass Pharma closed at its lowest level of the year, 33.5% below where the year started.
−7.3% · S&P 500 −0.6%
SpyGlass Pharma shares rose 12.6%, while the S&P 500 fell 0.7%.
+12.6%, on 1M shares, the year's heaviest volume · S&P 500 −0.7%
SpyGlass Pharma shares rose 12.2%, while the S&P 500 rose 0.4%.
+12.2% · S&P 500 +0.4%
EPS of $-0.59 missed the $-0.53 estimate on $0.00 revenue.
+2.3% · S&P 500 +0.6%
Where it ended: a close of $34.18 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 11, 2026 (EPS est. $-0.63).
Nothing in the past 12 months.
All SGP dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SGP and SPY from Benzinga historical bars. Not investment advice.
